作者：
J,Biau [1]
;
X,Durando [2]
;
F,Boux [3]
;
I,Molnar [1]
;
J,Moreau [4]
;
B,Leyrat [4]
;
F,Guillemin [4]
;
A,Lavielle [5]
;
Y,Cremillieux [6]
;
K,Seddik [7]
;
S,Dufort [7]
;
O,De Beaumont [7]
;
E,Thivat [8]
;
G,Le Duc [7]
作者单位：
Radiation Department, Centre Jean Perrin, Clermont-Ferrand F-63011 France.;University of Clermont Auvergne, UFR Médecine, Clermont-Ferrand, France.;INSERM U1240 IMoST, University of Clermont Auvergne, Clermont-Ferrand, FR-63000, France.;Centre d'Investigation Clinique UMR 501, Clermont-Ferrand F-63001, France.
[1]
University of Clermont Auvergne, UFR Médecine, Clermont-Ferrand, France.;INSERM U1240 IMoST, University of Clermont Auvergne, Clermont-Ferrand, FR-63000, France.;Centre d'Investigation Clinique UMR 501, Clermont-Ferrand F-63001, France.;Department of Clinical Research, Délégation Recherche Clinique et Innovation, Centre Jean Perrin, F-63011 Clermont-Ferrand, France.;Oncology Department, Centre Jean Perrin, Clermont-Ferrand F-63011 France.
[2]
Oncology Department, Centre Jean Perrin, Clermont-Ferrand F-63011 France.
[3]
Radiation Department, Centre Jean Perrin, Clermont-Ferrand F-63011 France.;University of Clermont Auvergne, UFR Médecine, Clermont-Ferrand, France.
[4]
NH TherAguix SA, Meylan, France.;Institut des Sciences Moléculaires, UMR5255, Université de Bordeaux, France.
[5]
Institut des Sciences Moléculaires, UMR5255, Université de Bordeaux, France.
[6]
NH TherAguix SA, Meylan, France.
[7]
University of Clermont Auvergne, UFR Médecine, Clermont-Ferrand, France.;INSERM U1240 IMoST, University of Clermont Auvergne, Clermont-Ferrand, FR-63000, France.;Centre d'Investigation Clinique UMR 501, Clermont-Ferrand F-63001, France.
[8]
DOI
10.1016/j.ctro.2024.100833
PMID
39184998
发布时间
2024-08-27
换一批
换一批
